Merz North America Announces End of Court-Ordered Injunction
By Jeremy Summers, NCBiotech Writer
Merz North America, which includes Merz Aesthetics, Inc. and Greensboro's Merz Pharmaceuticals, LLC, said a court-ordered injunction has been lifted, releasing its products to the marketplace.
The expiration of the injunction, which was imposed last March, gives patients and physicians access to a broader range of treatment options in aesthetic medicine, dermatology, and neurology, the company said.
“The violations that led to this injunction were directly attributable to the acts of several individuals, and were entirely incompatible with Merz’s culture,” said Katrina Church, vice president and chief compliance officer of Merz, Inc.
“We accepted the injunction as a challenge to us to reinforce compliance training throughout the company and to re-imagine a company-wide compliance program. Last summer, we directed all our efforts and resources toward the remediation process and were pleased when the court agreed to a partial lift of the injunction in November 2012. We believe that compliance policies are an investment in our company’s future,” said Church.
The company is now able to sell and promote its entire portfolio of FDA-approved products, which had been restricted under the injunction.
“Never at any point did the injunction question the quality of Merz’s products,” said Bill Humphries, president and chief executive officer of Merz, Inc. “Although the injunction represented a challenge to our business activities, I am proud to announce that during those ten months, we continued to advance our core business...and naming and staffing our Merz North American Leadership Team. Moving into 2013, our focus will be on sales and marketing execution in the marketplace, business development and licensing, and the organic expansion of our pipeline to better serve patients and physicians. We look forward to expanding our leadership role in dermatology within prescription anti-fungals, continuing our growth trajectory in movement disorders and commercializing our full suite of aesthetic products.”
Merz employs more than 100 people at the Greensboro facility.